HC Wainwright & Co. Reiterates Buy on IVERIC bio, Maintains $35 Price Target

HC Wainwright & Co. analyst Matthew Caufield reiterates IVERIC bio (NASDAQ:ISEE) with a Buy and maintains $35 price target.

HC Wainwright & Co. analyst Matthew Caufield reiterates IVERIC bio (NASDAQ:ISEE) with a Buy and maintains $35 price target.

Total
0
Shares
Related Posts
Read More

Traders’ Doubt Loom Over Tapestry-Capri Deal Amid Regulatory Scrutiny: Report

Doubts cloud Tapestry Inc's (NYSE:TPR) $8.5 billion merger with Capri Holdings Ltd (NYSE:CPRI), as traders question antitrust approval despite CEO's optimism. Luxury giants Coach, Kate Spade, and Michael Kors are at stake in the deal, attracting regulatory scrutiny. Capri's stock drop of 11% signals market skepticism, contrasting Tapestry's $57-per-share bid.

CPRI